-

Mirion Announces Earnings Release and Conference Call Date for First Quarter 2025

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that it will release financial results for first quarter 2025 after market close on Tuesday, April 29, 2025. Following the news release, the company will host a conference call the next day, Wednesday, April 30, 2025, at 11:00 am ET to discuss the results.

Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available at https://ir.mirion.com/news-events.

A telephonic replay will be available shortly after the conclusion of the call and until May 14, 2025. Participants may access the replay at 1-844-512-2921 or 1-412-317-6671 with access code 13753466. An archived replay of the call will also be available on the Investors portion of the Mirion website at https://ir.mirion.com/.

About Mirion

Mirion (NYSE: MIR) is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. The Mirion Nuclear & Safety group provides proven radiation safety technologies that operate with precision – for essential work within R&D labs, critical nuclear facilities, and on the front lines. The Mirion Medical group solutions help enhance the delivery and ensure safety in healthcare, powering the fields of Nuclear Medicine, Radiation Therapy QA, Occupational Dosimetry, and Diagnostic Imaging. Headquartered in Atlanta (GA – USA), Mirion employs approximately 2,800 people and operates in 12 countries. Learn more at mirion.com.

Contacts

For investor inquiries, please contact:
Eric Linn
ir@mirion.com

Industry:

Mirion

NYSE:MIR
Release Versions
English

Contacts

For investor inquiries, please contact:
Eric Linn
ir@mirion.com

More News From Mirion

Mirion Announces First Quarter 2025 Financial Results and Updates Full Year Guidance

ATLANTA--(BUSINESS WIRE)--Mirion (“we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and research end markets, today announced results for the first quarter ended March 31, 2025. “We delivered a strong start to the year, with year-over-year revenue growth and adjusted free cash flow generation,” commented Mirion’s Chairman and Chief Executive Officer Thomas Logan. “Additionally, order en...

Mirion to Elevate Radiopharmaceutical Production Quality with Advanced Apex-Guard Software

ATLANTA--(BUSINESS WIRE)--Mirion Technologies (NYSE: MIR), a global provider of advanced radiation safety solutions, today announced the latest release of its Apex-Guard gamma spectroscopy software. Tailored to meet the stringent regulatory demands of commercial radioisotope producers, Apex-Guard software V1.2 significantly enhances the Mirion solutions suite within the radiopharmaceutical supply chain with a robust impurity analysis for radioisotope producers. This software release reinforces...

Mirion Technologies Awarded Contracts for TerraPower Natrium® Reactor Demonstration Project

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR), a global leader in radiation safety, science, and medicine, has been selected to supply the Radiation Monitoring System (RMS) and Nuclear Instrumentation System (XIS) to support the Natrium Reactor Demonstration Project in Wyoming. This project marks the first commercial advanced nuclear power plant in the U.S. and is a public-private partnership between TerraPower, a leading nuclear innovation company, and the U.S. Department of Energy (DOE). The g...
Back to Newsroom